What is Amgen's change in accrued liabilities?

Amgen (AMGN) reported change in accrued liabilities of -$959M in Q1 2026.

How has Amgen's change in accrued liabilities changed year-over-year?

Amgen's change in accrued liabilities decreased by 9.7% year-over-year, from -$874M to -$959M.

What is the long-term trend for Amgen's change in accrued liabilities?

Over 2 years (2022 to 2025), Amgen's change in accrued liabilities has grown at a 126.8% compound annual growth rate (CAGR), from $97M to $499M.

What does change in accrued liabilities mean?

Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.

Amgen AMGN Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

Nektar TherapeuticsNKTR

$2.33M+91.4%

Oruka Therapeutics, Inc.ORKA

-$1.3M-156%

Rigel PharmaceuticalsRIGL

-$5.91M-43.5%

Jazz PharmaceuticalsJAZZ

-$7.9M-104%

Protagonist TherapeuticsPTGX

-$10.79M+8.7%

Viking TherapeuticsVKTX

$15.86M+376%

Other financials

Income statement

See full

Revenue$8.6B+5.8%

Gross profit$5.9B+13.4%

Operating income$2.7B+126%

Net income$1.8B+5.1%

EPS (diluted)$3.34+4.4%

Balance sheet

See full

Cash & equivalents$559.0M+10.0%

Total debt$57.3B-0.1%

Total equity$9.2B+48.1%

Total assets$92.5B+3.5%

Cash flow

See full

Operating cash flow$2.2B+57.4%

CapEx$712.0M+73.2%

Free cash flow$1.5B+50.7%

Valuation

See full

Market cap$195.44B+34.6%

Enterprise value$252.2B+25.7%

P/E25.1×+3.1×

P/S5.3×+1.1×

Profitability

See full

Gross margin68.3%+5.3pp

Operating margin28.4%+6.6pp

Net margin21%+3.6pp

FCF margin23.1%-8.9pp

Returns & leverage

See full

Return on equity101.3%-4.4pp

Debt / equity6.2×-3.0×

Current ratio1.3×+0.1×

Where this comes from

Reported directly by Amgen in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.

The official record: Amgen’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amgen's change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Amgen's change in accrued liabilities?: Amgen (AMGN) reported change in accrued liabilities of -$959M in Q1 2026.
How has Amgen's change in accrued liabilities changed year-over-year?: Amgen's change in accrued liabilities decreased by 9.7% year-over-year, from -$874M to -$959M.
What is the long-term trend for Amgen's change in accrued liabilities?: Over 2 years (2022 to 2025), Amgen's change in accrued liabilities has grown at a 126.8% compound annual growth rate (CAGR), from $97M to $499M.
What does change in accrued liabilities mean?: Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.